VA Leaders Questioned On Response To Suicide Risk In Agency Study
By Stephen Spotswood
Posted: 29-July-2008
WASHINGTON—In what is becoming a regular ritual on Capitol Hill, legislators took Department of Veterans Affairs (VA) leaders to task last month, this time for a possible breakdown in the agency’s human subject protection system of a study on combining smoking cessation therapy with therapy for post-traumatic stress disorder (PTSD). The study began in 2004 and was designed to determine whether smoking cessation therapy would be better implemented when combined with PTSD therapy, or whether treatments should be kept separate. Irregularities came to light in June in news reports that highlighted the discovery of suicide as being a possible side effect of Chantix, one of the smoking cessation drugs administered to some patients in the study, and VA’s delayed notification of study participants taking the drug of those side effects.
Read the full story here
www.usmedicine.com Link
Posted: 29-July-2008
WASHINGTON—In what is becoming a regular ritual on Capitol Hill, legislators took Department of Veterans Affairs (VA) leaders to task last month, this time for a possible breakdown in the agency’s human subject protection system of a study on combining smoking cessation therapy with therapy for post-traumatic stress disorder (PTSD). The study began in 2004 and was designed to determine whether smoking cessation therapy would be better implemented when combined with PTSD therapy, or whether treatments should be kept separate. Irregularities came to light in June in news reports that highlighted the discovery of suicide as being a possible side effect of Chantix, one of the smoking cessation drugs administered to some patients in the study, and VA’s delayed notification of study participants taking the drug of those side effects.
Read the full story here
www.usmedicine.com Link
Search our Hypnosis Site below:
posted by Mark Barrus (888) 865 -1870 @ 6:22 PM
Links to this post:
Create a Link
<< Home